CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a new method for delivering anti-cancer drugs non-invasively using advanced technologies. It combines encapsulation techniques, ultrasound-triggered release, and enhanced drug uptake to improve treatment efficacy while ensuring safety and flexibility in drug selection.
Clinical drug delivery (DD) remains a problem of heightened industrial and academic interest.
The proposed partnership seeks to embrace the problem by exploiting the unique expertise-base spanning the industrial research and academic pratners.
We will provide inter-sectoral training of mulit-disciplinary researchers and create a novel new DD modality that addresses the key critical needs for non-invasive therapy via intelligent generic targeting and with intrinsic flexibility in drug choice. A…
UNIVERSITY OF DUNDEE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Israel, TIRAT CARMEL
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Israel, NAZARETH ILLIT
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
